Roivant Sciences Executive Sells 200,000 Shares
I'm PortAI, I can summarize articles.
Eric Venker, President & Immunovant CEO of Roivant Sciences Ltd., sold 200,000 common shares on January 12, 2026, at a weighted average price of $21.92, totaling $4,384,000. Following the transaction, Venker directly owns 1,654,597 common shares of the company.Reporter NameVenker EricRelationshipPresident & Immunovant CEOTypeSellAmount$4,384,000SEC FilingForm 4SEC Filing: Roivant Sciences Ltd. [ ROIV ] - Form 4 - Jan. 14, 2026DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments